Singapore markets closed

Gilead Sciences, Inc. (GILD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
69.56-0.11 (-0.16%)
At close: 04:00PM EST
69.10 -0.46 (-0.66%)
After hours: 07:53PM EST
Sign in to post a message.
  • k
    kastenz
    Reports that PFE will shortly have a pill form protease disruptor for OMICRON. Does GILD have REMY in pill form yet?
  • J
    Jansen
    Gilead Statement on Veklury® (Remdesivir) and the SARS-CoV-2 Omicron Variant
    Foster City, Calif., December 1, 2021

    https://www.gilead.com/news-and-press/company-statements/gilead-statement-on-veklury-remdesivir-and-the-sars-cov-2-omicron-variant?s=09
  • S
    Sharbe
    Max pain for today's calls is $70. However the big one to watch is the Dec. 17 $70 calls. Huge open interest. 14,000 contracts.
  • C
    Cofi'Cream
    Gilead Sciences Says Believes Veklury Will Continue To Be Effective Against Currently Identified Variants Including Omicron.
  • A
    Anonymous
    Dont worry guys there will be more gov money spent on new vaccines and merk and pfizer will make covid drugs that the government will buy before they are even manufactured. Meanwhile at Gilead… O’day is still in charge just keep up the faith and hope. Meanwhile i sold 75% at $70.29 You are welcome jim.
  • T
    Tuan
    Perhaps, later Remy proved effectively against Omicron, the only one working. Then Gilead would be easy $100. I got strong feeling and confidence in this drug.
  • v
    vivamiga
    Seems like Yahoo works with Gilead to take down uncomfortable posts. This is very interesting about a patent granted to WIV for modified Remdesivir. This is the tweet: https://twitter.com/victoriacyanide/status/1465373426068037633
  • J
    John
    So new covid variant.... yeah this is not over.... the unvaccinated in hospital..... win for Gilead and Remdesivir.... strong buy
  • w
    wes
    "Merck's COVID-19 pill shows lower efficacy in updated data"
  • K
    Kjinman
    No better time to announce an acquisition than during a broad market sell off. Only the strong will survive! 2 for 1 with Merck...Let's go!
  • M
    Medusa
    25th November 2021 – (Hong Kong) According to Sky News, A new variant of the coronavirus with a “constellation” of mutations has been identified in Botswana. Designated as B.1.1.529, scientists are still unclear whether existing antibodies would react well to the variant – which has 32 spike protein mutations. Spike proteins are what viruses use to get into human cells, and some of the vaccines work by training the body to recognise the spikes and neutralise them. Mutations on the spike can therefore potentially prove problematic for mRNA doses, like Pfizer and Moderna. However, with only a handful of recorded cases – three in Botswana, six in South Africa and one in Hong Kong from someone who travelled from South Africa, scientists are hopeful that COVID cases caused by the new virus specimen will not be widespread
  • B
    BioPharmaInvestor
    MTNB's LNC platform delivery technology is PERFECT....for Gilead's HIV treatments AND.....Remdesivir. Will Gilead make a move for MTNB if their Oral LNC Remdesivir collaboration with NIH produces a treatment that is superior to PFE's and MRK's covid pills ? That is the $100 million dollar question. Best wishes to all.
  • R
    Rocky
    REMDESIVIR!!!!
  • d
    diamond
    …amidst all the sound and the fury
    just back from the lab comes the jury
    it’s abundantly clear
    that our remdesivir
    veklury, veklury, veklury
  • F
    Frank B
    Buy Gilead see what happens when the market dives and this company makes money
  • T
    Tuan
    What would we wait for Gilead in the future. I meant 4 th quarter 2021.
    1) on the up side. The upsellings of Trodelvy, the filing of Magrolimab, and The good or recorded sellings of Remy.
    The best I guess Gild may climb up to 75 and stay at 80 after earning.
    2) on the down side, if Pfizer’s or Merck’s pills get FDA. Surely, Gilead would go down until quarter reports later showing that Gild revenues still move forward with or with out those pill causes.
    Then, I guess Gilead would go to the range 60-65. I lean to FDA decisions would be next year.
    I am in for Gilead long investment not because of Remy. I believe in their oncology strategy.
    I would be hit when the downside come. I guess the upside come first, then the down side , and finaly the more permanent up sides. So, I adjust my investment in Gilead along with what I see. I am already bought back all my put options $60. Got some gains but I brought a little soon. Does not matter as long as I got some in the last down side so my Gilead shares could build up. Now I start selling Gilead call options at 77.5 and take $1 per share due sometime in next Feb. I think it is pretty safe for gild price not to go over and I still can get those free bucks. This operation is just start and I will sell more if gild goes up $2-3 bucks from 70. Those cycles I do it repeatedly in last 2 years. It works with gilead.
  • T
    Tuan
    Why does Gilead seem not planning to develop vaccines? They got huge financial to support this. Giant drug companies make vaccines. Gilead grows big they got to to it too.
  • b
    bill
    No worries….the 3 stooges will once again come on here and tell us “well, the whole market is down”! Again, when you ask them if that is their theory, why is it when “the whole market was doubling” from the early pandemic lows, GILD was dropping from 83 to 56??? Hmmmm? Change the quarterback and we will soar! GLTAL!!
  • R
    Rocky
    Manipulation @ best …